Effects of gender, age and menopausal status on serum apolipoprotein concentrations

Clinical Endocrinology

Volumn 85, Issue 5, 2016, Pages 733-740

  Anagnostis, Panagiotis ^a   Stevenson, John C ^b   Crook, David ^c   Johnston, Desmond G ^a   Godsland, Ian F ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84991275544     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.13085     Document Type: Article

References (30)

1. Dosi, R., Bhatt, N., Shah, P. et al. (2014) Cardiovascular disease and menopause. Journal of Clinical and Diagnostic Research, 8, 62–64.
2. Gordon, T., Kannel, W.B., Hjortland, M.C. et al. (1978) Menopause and coronary heart disease. The Framingham Study. Annals of Internal Medicine, 89, 157–161.
3. Godsland, I.F., Wynn, V., Crook, D. et al. (1987) Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. American Heart Journal, 114, 1467–1503.
4. Stevenson, J.C., Crook, D. & Godsland, I. F. (1993) Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis, 98, 83–90.
5. Anagnostis, P., Stevenson, J.C., Crook, D. et al. (2015) Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas, 81, 62–68.
6. Abbey, M., Owen, A., Suzakawa, M. et al. (1999) Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas, 33, 259–269.
7. Salhotra, S., Arora, S., Anubhuti, et al. (2009) Influence of menopause on biochemical markers of endothelial dysfunction-A case-control pilot study in North Indian population. Maturitas, 62, 166–170.
8. Muzzio, M.L., Miksztowicz, V., Repetto, E.M. et al. (2012) Increased MMP-2 in healthy postmenopausal women. Annals of Clinical Biochemistry, 49, 75–79.
9. Walldius, G., Jungner, I., Holme, I. et al. (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet, 358, 2026–2033.
10. St-Pierre, A.C., Cantin, B., Dagenais, G.R. et al. (2006) Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men. American Journal of Cardiology, 97, 997–1001.
11. Shai, I., Rimm, E.B., Hankinson, S.E. et al. (2004) Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation, 110, 2824–2830.
12. Benn, M. (2009) Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review. Atherosclerosis, 206, 17–30.
13. McQueen, M.J., Hawken, S., Wang, X. et al. (2008) Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet, 372, 224–233.
14. Maïga, S.F., Kalopissis, A.D. & Chabert, M. (2014) Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes. Biochimie, 96, 56–66.
15. Atta, M., Crook, D., Shafique, F. et al. (2008) Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II. Thrombosis and Haemostasis, 100, 391–396.
16. Ikenoue, N., Wakatsuki, A. & Okatani, Y. (1999) Small low-density lipoprotein particles in women with natural or surgically induced menopause. Obstetrics and Gynecology, 93, 566–570.
17. Li, Z., McNamara, J.R., Fruchart, J.C. et al. (1996) Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. Journal of Lipid Research, 37, 1886–1896.
18. Matthews, K.A., Crawford, S.L., Chae, C.U. et al. (2009) Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of the American College of Cardiology, 54, 2366–2373.
19. Bayrak, A., Aldemir, D.A., Bayrak, T. et al. (2006) The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Archives of Gynecology and Obstetrics, 274, 289–296.
20. Bonithon-Kopp, C., Scarabin, P.Y., Darne, B. et al. (1990) Menopause-related changes in lipoproteins and some other cardiovascular risk factors. International Journal of Epidemiology, 19, 42–48.
21. Dallongeville, J., Marecaux, N., Isorez, D. et al. (1995) Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis, 118, 123–133.
22. Campos, H., McNamara, J.R., Wilson, P.W. et al. (1988) Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 67, 30–35.
23. Peters, H., Westendorp, I., Hak, A.E. et al. (1999) Menopausal status and risk factors for cardiovascular disease. Journal of Internal Medicine, 246, 521–528.
24. Murano, T., Izumi, S., Kika, G. et al. (2003) Impact of menopause on lipid and bone metabolism and effect of hormone replacement therapy. Tokai Journal of Experimental and Clinical Medicine, 28, 109–119.
25. Lyu, L.C., Yeh, C.Y., Lichtenstein, A.H. et al. (2001) Association of sex, adiposity, and diet with HDL subclasses in middle-aged Chinese. American Journal of Clinical Nutrition, 74, 64–71.
26. Brinton, E.A. (1996) Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 431–440.
27. Jin, F., Kamanna, V. & Kashyap, M. (1998) Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 999–1006.
28. Walsh, B.W., Schiff, I., Rosner, B. et al. (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New England Journal of Medicine, 325, 1196–1204.
29. Ley, C., Lees, B. & Stevenson, J. (1992) Sex- and menopause-associated changes in body fat distribution. American Journal of Clinical Nutrition, 55, 950–954.
30. Hodson, L., Banerjee, R., Rial, B., et al. (2015) Menopausal status and abdominal obesity are significant determinants of hepatic lipid metabolism in women. Journal of the American Heart Association, 4, e002258.